good grief. @ retiredyoung has been updating those of you who cant understand cashflows what the situation was at least monthly
the point is that the fakemakery in the activity statements almost never reflects the cashflow just-in-time challenges. money almost always comes in later and costs are higher - and bod's always require an elegant sufficiency of cash as safety to meet audit 'going concern' questions. add to that the obvious issues related to meeting high monthly interest rate fees.... as i said back when it was mooted in fbeb - thats a horrible high risk way to try to finance a growth stock
this is true of nearly all growth stocks not just bud - its in the nature of toddler companies that outcomes are hard to predict.
though there's some singular issues on this particular stock that make it more dooztatstic. esp unwillingness to stop ropeadoping retail with on-the-edge forward looks they repeatedly fail to meet
this playbook is almost direct repeat of 2017 - even down to reason for cr - except with backdrop of plummeting investor confidence
just hope aks4058 wized up last year and got out. anyone who invested $10s-$100s of ks as it dropped from ~12c is going to be in a world of hurt for a long time if in fact it doesnt go out the back door
if you do nothing else from here - pay attention to what
@retiredyoung posts